Patents by Inventor Anna Sophia McKenney

Anna Sophia McKenney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment of myeloproliferative neoplasm
    Patent number: 11833154
    Abstract: Provided are methods and compositions for treating myeloproliferative neoplasms in patients carrying an IDH2 mutation and a JAK2 mutation.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: December 5, 2023
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Ross L. Levine, Anna Sophia McKenney
  • METHODS OF TREATMENT OF MYELOPROLIFERATIVE NEOPLASM
    Publication number: 20220105097
    Abstract: Provided are methods and compositions for treating myeloproliferative neoplasms in patients carrying an IDH2 mutation and a JAK2 mutation.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Inventors: Ross L. Levine, Anna Sophia McKenney
  • Methods of treatment of myeloproliferative neoplasm
    Patent number: 11229653
    Abstract: Provided are methods and compositions for treating myeloproliferative neoplasms patients carrying an IDH2 mutation and a JAK2 mutation.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: January 25, 2022
    Assignee: Celgene Corporation
    Inventors: Ross L. Levine, Anna Sophia McKenney
  • METHODS OF TREATMENT OF MYELOPROLIFERATIVE NEOPLASM
    Publication number: 20200155559
    Abstract: Provided are methods and compositions for treating myeloproliferative neoplasms patients carrying an IDH2 mutation and a JAK2 mutation.
    Type: Application
    Filed: May 4, 2018
    Publication date: May 21, 2020
    Inventors: Ross L. Levine, Anna Sophia McKenney